Identifying the interaction between influenza and pneumococcal pneumonia using incidence data

Science Translational Medicine

Volumn 5, Issue 191, 2013, Pages

  Shrestha, Sourya ^a   Foxman, Betsy ^a   Weinberger, Daniel M ^b,c   Steiner, Claudia ^d   Viboud, Cécile ^b   Rohani, Pejman ^a,b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c YALE UNIVERSITY   (United States)

^d AGENCY FOR HEALTHCARE RESEARCH AND QUALITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL TRANSMISSION; EPIDEMIC; HUMAN; INCIDENCE; INFECTION RISK; INFECTION SENSITIVITY; INFLUENZA; MAJOR CLINICAL STUDY; MATHEMATICAL MODEL; PRIORITY JOURNAL; SEASONAL INFLUENZA; STREPTOCOCCUS PNEUMONIA;

COINFECTION; HUMANS; INCIDENCE; INFLUENZA, HUMAN; PNEUMONIA, PNEUMOCOCCAL; STREPTOCOCCUS PNEUMONIAE;

EID: 84880556333     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3005982     Document Type: Article

References (62)

1. T. N. Petney, R. H. Andrews, Multiparasite communities in animals and humans: Frequency, structure and pathogenic significance. Int. J. Parasitol. 28, 377-393 (1998).
2. P. Rohani, C. J. Green, N. B. Mantilla-Beniers, B. T. Grenfell, Ecological interference between fatal diseases. Nature 422, 885-888 (2003).
3. J. Lello, B. Boag, A. Fenton, I. R. Stevenson, P. J. Hudson, Competition and mutualism among the gut helminths of a mammalian host. Nature 428, 840-844 (2004).
4. R. Pullan, S. Brooker, The health impact of polyparasitism in humans: Are we under-estimating the burden of parasitic diseases? Parasitology 135, 783-794 (2008).
5. E. C. Griffiths, A. B. Pedersen, A. Fenton, O. L. Petchey, The nature and consequences of coinfection in humans. J. Infect. 63, 200-206 (2011).
6. S. Telfer, X. Lambin, R. Birtles, P. Beldomenico, S. Burthe, S. Paterson, M. Begon, Species interactions in a parasite community drive infection risk in a wildlife population. Science 330, 243-246 (2010).
7. S. Shrestha, A. A. King, P. Rohani, Statistical inference for multi-pathogen systems. PLoS Comput. Biol. 7, e1002135 (2011).
8. A. A. Bosch, G. Biesbroek, K. Trzcinski, E. A. M. Sanders, D. Bogaert, Viral and bacterial interactions in the upper respiratory tract. PLoS Pathog. 9, e1003057 (2013).
9. J. A. McCullers, Insights into the interaction between influenza virus and pneumococcus. Clin. Microbiol. Rev. 19, 571-582 (2006).
10. D. M. Morens, J. K. Taubenberger, A. S. Fauci, Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: Implications for pandemic influenza preparedness. J. Infect. Dis. 198, 962-970 (2008).
11. D. M. Weinberger, L. Simonsen, R. Jordan, C. Steiner, M. Miller, C. Viboud, Impact of the 2009 influenza pandemic on pneumococcal pneumonia hospitalizations in the United States. J. Infect. Dis. 205, 458-465 (2012).
12. L. Simonsen, The global impact of influenza on morbidity and mortality. Vaccine 17 (Suppl. 1), S3-S10 (1999).
13. S. F. Dowell, C. G. Whitney, C. Wright, C. E. Rose Jr., A. Schuchat, Seasonal patterns of invasive pneumococcal disease. Emerg. Infect. Dis. 9, 573-579 (2003).
14. N. D. Walter, T. H. Taylor Jr., S. F. Dowell, S. Mathis, M. R. Moore; Active Bacterial Core Surveillance System Team, Holiday spikes in pneumococcal disease among older adults. N. Engl. J. Med. 361, 2584-2585 (2009).
15. C. G. Grijalva, J. P. Nuorti, P. G. Arbogast, S. W. Martin, K. M. Edwards, M. R. Griffin, Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: A time-series analysis. Lancet 369, 1179-1186 (2007).
16. D. B. Louria, H. L. Blumenfeld, J. T. Ellis, E. D. Kilbourne, D. E. Rogers, Studies on influenza in the pandemic of 1957-1958. II. Pulmonary complications of influenza. J. Clin. Invest. 38, 213-265 (1959).
17. M. Lindsay Jr., E. Herrmann Jr., G. Morrow Jr., A. Brown Jr., Hong Kong influenza: Clinical, microbiologic, and pathologic features in 127 cases. JAMA 214, 1825-1832 (1970).
18. A. L. Bisno, J. P. Griffin, K. A. Van Epps, H. B. Niell, M. W. Rytel, Pneumonia and Hong Kong influenza: A prospective study of the 1968-1969 epidemic. Am. J. Med. Sci. 261, 251-263 (1971).
19. J. R. Gill, Z. M. Sheng, S. F. Ely, D. G. Guinee, M. B. Beasley, J. Suh, C. Deshpande, D. J. Mollura, D. M. Morens, M. Bray, W. D. Travis, J. K. Taubenberger, Pulmonary pathologic findings of fatal 2009 pandemic influenza A/H1N1 viral infections. Arch. Pathol. Lab. Med. 134, 235-243 (2010).
20. J. A. McCullers, J. E. Rehg, Lethal synergism between influenza virus and Streptococcus pneumoniae: Characterization of a mouse model and the role of platelet-activating factor receptor. J. Infect. Dis. 186, 341-350 (2002).
21. K. Sun, D. M. Metzger, Inhibition of pulmonary antibacterial defense by interferon-g during recovery from influenza infection. Nat. Med. 14, 558-564 (2008).
22. I. Kukavica-Ibrulj,M. E. Hamelin, G. A. Prince, C. Gagnon, Y. Bergeron,M. G. Bergeron, G. Boivin, Infection with human metapneumovirus predisposes mice to severe pneumococcal pneumonia. J. Virol. 83, 1341-1349 (2009).
23. J. A. McCullers, J. L. McAuley, S. Browall, A. R. Iverson, K. L. Boyd, B. H. Normark, Influenza enhances susceptibility to natural acquisition of and disease due to Streptococcus pneumoniae in ferrets. J. Infect. Dis. 202, 1287-1295 (2010).
24. D. A. Diavatopoulos, K. R. Short, J. T. Price, J. J. Wilksch, L. E. Brown, D. E. Briles, R. A. Strugnell, O. L. Wijburg, Influenza A virus facilitates Streptococcus pneumoniae transmission and disease. FASEB J. 24, 1789-1798 (2010).
25. N. D. Walter, T. H. Taylor, D. K. Shay, W. W. Thompson, L. Brammer, S. F. Dowell, M. R. Moore; Active Bacterial Core Surveillance Team, Influenza circulation and the burden of invasive pneumococcal pneumonia during a non-pandemic period in the United States. Clin. Infect. Dis. 50, 175-183 (2010).
26. S. P. Kuster, A. R. Tuite, J. C. Kwong, A. McGeer; Toronto Invasive Bacterial Diseases Network Investigators, D. N. Fishman, Evaluation of coseasonality of influenza and invasive pneumococcal disease: Results from prospective surveillance. PLoS Med. 8, e1001042 (2011).
27. A. Toschke, S. Arenz, R. von Kries, W. Puppe, J. Weigl, M. Höhle, U. Heininger, No temporal association between influenza outbreaks and invasive pneumococcal infections. Arch. Dis. Child. 93, 218-220 (2008).
28. R. M. Anderson, R. M. May, Infectious Diseases of Humans: Dynamics and Control (Oxford Univ. Press, Oxford, 1991).
29. M. Keeling, P. Rohani, Modelling Infectious Diseases (Princeton University Press, Princeton, NJ, 2008).
30. C. Bretó, D. He, E. L. Ionides, A. A. King, Time series analysis via mechanistic models. Ann. Appl. Stat. 3, 319-348 (2009).
31. E. L. Ionides, C. Bretó, A. A. King, Inference for nonlinear dynamical systems. Proc. Natl. Acad. Sci. U.S.A. 103, 18438-18443 (2006).
32. A. A. King, E. L. Ionides, M. Pascual, M. J. Bouma, Inapparent infections and cholera dynamics. Nature 454, 877-880 (2008).
33. A. A. King, E. L. Ionides, C. M. Breto, S. Ellner, B. Kendall, H. Wearing, M. J. Ferrari, M. Lavine, D. C. Reuman, pomp: Statistical inference for partially observed Markov processes (R package); http://pomp.r-forge.r-project. org.
34. C. Bottomley, V. Isham, M. G. Basáñez, Population biology of multispecies helminth infection: Interspecific interactions and parasite distribution. Parasitology 131, 417-433 (2005).
35. A. Fenton, M. E. Viney, J. Lello, Detecting interspecific macroparasite interactions from ecological data: Patterns and process. Ecol. Lett. 13, 606-615 (2010).
36. B. M. Gray, G. M. Converse III, H. C. Dillon Jr., Epidemiologic studies of Streptococcus pneumoniae in infants: Acquisition, carriage, and infection during the first 24 months of life. J. Infect. Dis. 142, 923-933 (1980).
37. D. Bogaert, R. De Groot, P. W. Hermans, Streptococcus pneumoniae colonisation: The key to pneumococcal disease. Lancet Infect. Dis. 4, 144-154 (2004).
38. D. M. Weinberger, Z. B. Harboe, E. A. Sanders, M. Ndiritu, K. P. Klugman, S. Rückinger, R. Dagan, R. Adegbola, F. Cutts, H. L. Johnson, K. L.O'Brien, J. A. Scott, M. Lipsitch, Association of serotype with risk of death due to pneumococcal pneumonia: A meta-analysis. Clin. Infect. Dis. 51, 692-699 (2010).
39. S. Nakamura, K. M. Davis, J. N. Weiser, Synergistic stimulation of type I interferons during influenza virus coinfection promotes Streptococcus pneumoniae colonization in mice. J. Clin. Invest. 121, 3657-3665 (2011).
40. HCUP SID Database Documentation, Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare Research and Quality, Rockville, MD; http://www.hcup-us.ahrq.gov/db/state/ siddbdocumentation.jsp.
41. D. He, E. L. Ionides, A. A. King, Plug-and-play inference for disease dynamics: Measles in large and small populations as a case study. J. R. Soc. Interface 7, 271-283 (2010).
42. E. L. Ionides, C. Breto, A. A. King, Modeling Disease Dynamics: Cholera as a Case Study (Wiley, Hoboken, NJ, 2007), chap. 8, pp. 13-140.
43. M. S. Arulampalam, S. Maskell, N. Gordon, T. Clapp, A tutorial on particle filters for online nonlinear/non-Gaussian Bayesian tracking. IEEE Trans. Signal Process. 50, 174-188 (2002).
44. D. M. Ferreira, K. C. Jambo, S. B. Gordon, Experimental human pneumococcal carriage models for vaccine research. Trends Microbiol. 19, 464-470 (2011).
45. S. Cobey, M. Lipsitch, Niche and neutral effects of acquired immunity permit coexistence of pneumococcal serotypes. Science 335, 1376-1380 (2012).
46. C. Reed, F. J. Angulo, D. L. Swerdlow, M. Lipsitch, M. I. Meltzer, D. Jernigan, L. Finelli, Estimates of the prevalence of pandemic (H1N1) 2009, United States, April-July 2009. Emerg. Infect. Dis. 15, 2004-2007 (2009).
47. S. S. Shrestha, D. L. Swerdlow, R. H. Borse, V. S. Prabhu, L. Finelli, C. Y. Atkins, K. Owusu-Edusei, B. Bell, P. S. Mead, M. Biggerstaff, L. Brammer, H. Davidson, D. Jernigan, M. A. Jhung, L. A. Kamimoto, T. L. Merlin, M. Nowell, S. C. Redd, C. Reed, A. Schuchat, M. I. Meltzer, Estimating the burden of 2009 pandemic influenza a (H1N1) in the United States (April 2009-April 2010). Clin. Infect. Dis. 52 (Suppl. 1), S75-S82 (2011).
48. A. M. Presanis, D. De Angelis; New York City Swine Flu Investigation Team, A. Hagy, C. Reed, S. Riley, B. S. Cooper, L. Finelli, P. Biedrzycki, M. Lipsitch, The severity of pandemic H1N1 influenza in the United States, from April to July 2009: A Bayesian analysis. PLoS Med. 6, e1000207 (2009).
49. J. F. Brundage, Interactions between influenza and bacterial respiratory pathogens: Implications for pandemic preparedness. Lancet Infect. Dis. 6, 303-312 (2006).
50. G. A. Soper, The pandemic in the army camps. JAMA 71, 1899-1909 (1918).
51. L. Robertson, J. P. Caley, J. Moore, Importance of Staphylococcus aureus in pneumonia in the 1957 epidemic of influenza A. Lancet 2, 233-236 (1958).
52. R. Oseasohn, L. Adelson, M. Kaji, Clinicopathologic study of thirty-three fatal cases of Asian influenza. N. Engl. J. Med. 260, 509-518 (1959).
53. S. W. Schwarzmann, J. L. Adler, R. J. Sullivan Jr., W. M. Marine, Bacterial pneumonia during the Hong Kong influenza epidemic of 1968-1969. Arch. Intern. Med. 127, 1037-1041 (1971).
54. W. J. Shieh, D. M. Blau, A. M. Denison, M. Deleon-Carnes, P. Adem, J. Bhatnagar, J. Sumner, L. Liu, M. Patel, B. Batten, P. Greer, T. Jones, C. Smith, J. Bartlett, J. Montague, E. White, D. Rollin, R. Gao, C. Seales, H. Jost, M. Metcalfe, C. S. Goldsmith, C. Humphrey, A. Schmitz, C. Drew, C. Paddock, T. M. Uyeki, S. R. Zaki, 2009 pandemic influenza A (H1N1): Pathology and pathogenesis of 100 fatal cases in the United States. Am. J. Pathol. 177, 166-175 (2010).
55. T.Mauad, L. A. Hajjar,G.D. Callegari, L. F. da Silva, D. Schout, F. R.Galas, V. A. Alves, D. M. Malheiros, J.O. Auler Jr., A. F. Ferreira,M. R. Borsato, S. M. Bezerra, P. S. Gutierrez, E. T. Caldini, C. A. Pasqualucci, M. Dolhnikoff, P. H. Saldiva, Lung pathology in fatal novel human influenza A (H1N1) infection. Am. J. Respir. Crit. Care Med. 181, 72-79 (2010).
56. G. Palacios, M. Hornig, D. Cisterna, N. Savji, A. V. Bussetti, V. Kapoor, J. Hui, R. Tokarz, T. Briese, E. Baumeister, W. I. Lipkin, Streptococcus pneumoniae coinfection is correlated with the severity of H1N1 pandemic influenza. PLoS One 4, e8540 (2009).
57. P. E. Kim, D. M. Musher, W. P. Glezen, M. C. Rodriguez-Barradas, W. K. Nahm, C. E. Wright, Association of invasive pneumococcal disease with season, atmospheric conditions, air pollution, and the isolation of respiratory viruses. Clin. Infect. Dis. 22, 100-106 (1996).
58. K. Grabowska, L. Högberg, P. Penttinen, Å. Svensson, K. Ekdahl, Occurrence of invasive pneumococcal disease and number of excess cases due to influenza. BMC Infect. Dis. 6, 58 (2006).
59. M. Watson, R. Gilmour, R. Menzies, M. Ferson, P. McIntyre; New South Wales Pneumococcal Network, The association of respiratory viruses, temperature, and other climatic parameters with the incidence of invasive pneumococcal disease in Sydney, Australia. Clin. Infect. Dis. 42, 211-215 (2006).
60. D. R. Murdoch, L. C. Jennings, Association of respiratory virus activity and environmental factors with the incidence of invasive pneumococcal disease. J. Infect. 58, 37-46 (2009).
61. A. G. Jansen, E. A. Sanders, A. M. van der Ende, A. W. van Loon, A. Hoes, E. Hak, Invasive pneumococcal and meningococcal disease: Association with influenza virus and respiratory syncytial virus activity? Epidemiol. Infect. 136, 1448-1454 (2008).
62. D. J. Earn, P. Rohani, B. M. Bolker, B. T. Grenfell, A simple model for complex dynamical transitions in epidemics. Science 287, 667-670 (2000).